differences between fetal and maternal macrophage activation states could potentially drive unique responses to infection and inflammatory stressors. Fetal HBCs also strongly express genes associated with M1 macrophage responses, suggesting more phenotypic diversity than previously described.
OBJECTIVE:
The inflammatory changes in the placenta that are intially associated with uterine quiescence but are later associated with labor and delivery need to be elucidated. During steady state, monocytes differentiate into macrophages that maintain tolerance and homeostasis. In inflammatory states, such as inflammatory bowel disease (IBD), this differentiation is arrested, the monocyte population increases and neutrophils accumulate. Additionally, these monocytes can differentiate into dendritic cells (DCs) capable of migrating into lymph nodes where thay can prime T cells and induce an immune response. We analyzed these alterations in placentas throughout normal pregnancy as compared to those observed in a mouse model of IBD. STUDY DESIGN: We utilized 6-8 week old CX 3 CR 1 -GFP mice (n¼25) in which the CD11b + myeloid cell populations are defined as: CX3CR 1 hi macrophages, CX3CR 1 int pro-inflammatory effector monocytes, and CX3CR 1 neg neutrophils. Under inflammatory conditions, these monocytes can give rise to CCR7-expressing CX 3 CR 1 int Ly6C lo DCs capable of migrating to the lymph nodes. We analyzed these cell populations by flow cytometry in single cell suspensions derived form placentas at designated time points in pregnancy (day 12,16,19) . We compared these results to those observed in colons from and IBD model, in which mice are fed with dextran sulfate sodium salt, that induces severe inflammation. RESULTS: Surprisingly, throughout normal pregnancy a predominant pro-inflammatory effector monocyte population accumulates in the placenta (Figure 1 ). This corrleates to the acute inflammatory phase in IBD. Before labor and delivery the resting macrophage population disappears and an influx of neutrophils is demonstrated. We also detected that before delivery moonocyte derived DCs upregulate the chemokine receptor CCR7 indicating a transition from a "tolerant"-to an "inflammatory" state from midpregnancy to term (Figure 2) . CONCLUSION: The myeloid cell population in the placenta is unique demonstrating a high prepondrance of pro-inflammatory monocytes. This resembles an inflammatory state as observed in IBD and not a steady state. Before labor these monocytes do not differentiate into resting macrophages but rather into inflammatory effector DCs capable of migrtaion into lymph nodes and primng an immune response. These new findings may help shed new light on the cellular mechanisms underlying the sterile inflammation leading to labor and dleivery. OBJECTIVE: Pregnancy is a challenge for the maternal immune system since it has to defend against pathogens while tolerating alloantigenic fetal tissue. Little is known about maternal brain immune system during pregnancy. During pregnancy there is a marked increase in endogenous progesterone (PRO) and PRO supplementation is used for prevention of preterm birth. We sought to determine the maternal brain immune response to inflammation in pregnant (P) and non-pregnant (NP) mice and whether PRO supplementation attenuates this response. STUDY DESIGN: NP & P mice were pretreated with vaginal PRO or carrier from E13-E16. Lipopolysaccharide (LPS 30mg) or vehicle were administered intraperitoneally at E15 & E16. Serum was analyzed for IL-6 levels by ELISA. Brain was analyzed for nNOS, NFkB, IL-6 & TNF-a levels by western blot. Brain immature myeloid cells (IMC; CD45 high , CD11b + , Gr1 + ) as % of CD45 high hematopoietic brain cells and microglial (CD45 low cells) activity as medial CD45 intensity was analyzed by FACS. RESULTS: LPS significantly increased brain nNOS, NFkB, IL-6 & TNF-a protein brain levels in NP & P mice. PRO pretreat ment significantly reduced nNOS and NFkB brain levels following LPS treatment in both groups. In NP mice, LPS treatment significant increased brain IMC population, and PRO pretreatment reduced the increase. In P mice, neither LPS nor LPS & PRO altered the brain IMC population. LPS led to a significant increase in microglial activity both groups. PRO pretreatment led to significant decrease in microglial activity in P mice. In NP mice, there was a trend but it did not reach statistical significance. PRO had no effect on serum IL-6 levels in both groups.
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